Financial Transparency Concerns Over Patient Groups Advising NICE
Executive Summary
England and Wales' cost-effectiveness agency has been urged to review its disclosure policy in a BMJ report which calls on NICE to probe the financial transparency of patient organizations that contribute to reimbursement assessments.